Better Treatments To Reverse Congestive Heart Failure
Take it easy… stay in bed. That’s what most doctors tell patients with congestive heart failure. I can’t think of worse advice. What’s Congestive Heart Failure? Congestive heart failure (CHF) means your heart can’t pump enough blood for your body’s needs. Blood builds up behind the heart. Fluids accumulate in the lungs and make you weak, tired and short of breath. Less blood flowing to your brain makes you dizzy and confused. Vital organs like your lungs, brain and kidneys begin to shut down. What Happens When You Have CHF? A heart with CHF is severely deconditioned. When your heart pumps less blood than it receives, fluid backs up. Your heart swells like a water balloon. How Can Congestive Heart Failure Be Treated? Like any muscle, the heart needs exercise to build strength — not rest. I help my heart patients build up their heart muscle with my PACE program. It’s the best way to improve your heart’s capacity and increase its pumping power. And it only takes 12 minutes a day. You can get specific workouts, resources and information about exercising with PACE by clicking here. Mainstream Treatments for CHF Bed rest isn’t the only bad advice cardiologists give CHF patients. They also prescribe Big Pharma drugs that make CHF worse. ACE inhibitors and diuretics cause constant fatigue, weakness and shortness of breath; Beta-blockers decrease cardiac output by blocking hormones that allow the heart to beat faster...
Publication date: Available online 1 April 2020Source: Autoimmunity ReviewsAuthor(s): Klaus Wirth, Carmen Scheibenbogen
Publication date: Available online 31 March 2020Source: Neurophysiologie CliniqueAuthor(s): Karim Jamal, Stéphanie Leplaideur, Chloé Rousseau, Sébastien Cordillet, Annelise Moulinet Raillon, Simon Butet, Armel Cretual, Isabelle Bonan
Authors: Corrà U, Piepoli M, Giordano A Abstract Exercise oscillatory ventilation (EOV) is an ominous sign in heart failure due to reduced left ventricular ejection fraction (HFrEF) whatever it is represented. But EOV is detected also in normal healthy individuals and in other cardiovascular disease (CVD) patients, however, its prevalence in these is not completed clear. The aim was to describe the occurrence of EOV in healthy subjects and the overall population all CVD patients who performing symptom limited cardiopulmonary exercise testing (CPET). Healthy subjects were divided in athletes and normal subjec...
CONCLUSION Relatively low use of technology may limit potential for health technology innovation for people of advanced age. Socioeconomic and ethnic disparities will amplify this. PMID: 32223848 [PubMed - in process]
Authors: Chalikias G, Kikas P, Thomaidis A, Rigopoulos P, Pistola A, Lantzouraki A, Zisimopoulos A, Tziakas D Abstract We assessed the effect of Sacubitril/Valsartan on circulating catecholamine levels in patients with HF in an observational cohort study. We included 108 consecutive HF patients attending our HF Outpatients Clinic who were eligible to Sacubitril/Valsartan according to the PARADIGM-HF inclusion and exclusion criteria. We furthermore included 58 stable HF patients under optimal medical therapy as a control group. Norepinephrine and epinephrine were measured with immunoradiometric assays at baseline, a...
In this report, we describe two patients with anticentriole antibodies-positive SSc-PAH who were treated with pulmonary vasodilators. Both cases were elderly women with poor physical conditions and clinical findings of SSc. Case 1 was resistant to combination therapy with pulmonary vasodilators; in Case 2, hemodynamic improvement was obtained by upfront combination therapy at an early stage. Because anticentriole antibodies-positive SSc-PAH rapidly deteriorates, careful hemodynamic observation and timely aggressive use of pulmonary vasodilators should be considered. PMID: 32224603 [PubMed - in process]
Authors: Sugimoto K, Yoshihisa A, Nakazato K, Yokokawa T, Misaka T, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Ishida T, Takeishi Y Abstract Pulmonary hypertension (PH) caused by left-sided heart disease (LHD-PH) is classified into 2 types: isolated post-capillary PH (Ipc-PH) and combined pre- and post-capillary PH (Cpc-PH). However, the impact of pulmonary vascular resistance (PVR) or diastolic pressure gradient (DPG) on the prognosis of LHD-PH has varied among previous studies. Thus, we verified the significance of PVR or DPG on the prognosis of LHD-PH in our series.We analyzed 243 consecutive LHD-PH patients. The...
Authors: Maki H, Takeda N PMID: 32224600 [PubMed - in process]
Org. Biomol. Chem., 2020, Advance Article DOI: 10.1039/D0OB00437E, PaperMaina Takahashi, Junya Shirasaki, Naoko Komura, Katsuaki Sasaki, Hide-Nori Tanaka, Akihiro Imamura, Hideharu Ishida, Shinya Hanashima, Michio Murata, Hiromune Ando GM3 gangliosides have been synthesizedvia late-stage α-sialylation using a macro-bicyclic sialyl donor.19F solid-state NMR analysis of the C5-NHTFAc GM3 analog on a model membrane revealed the influence of cholesterol on glycan dynamics. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
CONCLUSION: TT extract and its saponin fraction exerted anti-inflammatory effects on HUVEC and HBMEC lines and reduced the expression of ICAM-1, VCAM-1, and E-selectin. However, the anti-inflammatory effect of aqueous extract was greater than that of saponin fraction. Therefore, TT could be considered as a potential candidate for the treatment or prevention of atherosclerosis. PMID: 32224542 [PubMed - in process]
More News: Bananas | Beta-Blockers | Brain | Cabbage | Cardiology | Cholesterol | Chronic Fatigue Syndrome | Complementary Medicine | Congestive Heart Failure | Health | Heart | Heart Disease | Heart Failure | Hormones | Hypertension | Kiwi | Mitochondria | Neurology | Nutrition | Pharmaceuticals | Skin | Sports Medicine | Statin Therapy | Statistics | Stroke | Study | Sweet Potato | Urology & Nephrology